• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JVI: A Novel Activation Mechanism of Avian Influenza Virus H9N2 by Furin

tetano

Editor, Senior Moderator
Published ahead of print 20 November 2013, doi: 10.1128/JVI.02648-13 JVI.02648-13



A Novel Activation Mechanism of Avian Influenza Virus H9N2 by Furin

Longping V. Tse1,2,
Alice M. Hamilton1,
Tamar Friling1 and
Gary R. Whittaker1,2*

+ Author Affiliations

1Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca NY 14853
2New York Center of Excellence for Influenza Research and Surveillance, University of Rochester Medical Center, Rochester NY 14627

ABSTRACT

Avian influenza H9N2 is prevalent in waterfowl and has become endemic in poultry in Asia and the Middle East. H9N2 influenza viruses have served as a reservoir of internal genes for other influenza viruses that infect humans, and several cases of human infection by H9N2 influenza viruses have indicated its pandemic potential. Fortunately, an extensive surveillance program enables close monitoring of H9N2 influenza viruses worldwide and has generated a large repository of virus sequences and phylogenetic information. Despite the large quantity of sequences in different databases, very little is known about specific virus isolates and their pathogenesis. Here, we characterize a low pathogenicity avian influenza virus (LPAI), A/chicken/Israel/810/2001 (H9N2), which is representative of influenza virus strains that have caused severe morbidity and mortality in poultry farms. We show that under certain circumstances the Israel810 HA can be activated by furin, a hallmark of highly pathogenic avian influenza virus (HPAI). We demonstrate that Israel810 HA can be cleaved in cells with high levels of furin expression, and that a mutation that eliminates a glycosylation site in HA1 allows the Israel810 HA to gain universal cleavage in cell culture. Pseudoparticles generated from Israel810 HA, or the glycosylation mutant, transduce cells efficiently. In contrast, introduction of a polybasic cleavage site into Israel810 HA leads to pseudoviruses that are compromised for transduction. Our data indicate a mechanism for an H9N2 evolutionary pathway that may allows it to gain virulence in a distinct manner from H5 and H7 influenza viruses.

http://jvi.asm.org/content/early/2013/11/15/JVI.02648-13.abstract
 
Back
Top Bottom